M&As, restructuring to sweep pharmaceutical industry

The government’s tougher action against illegal rebates in the local pharmaceutical industry is making it harder for small- and medium-sized firms to do business.

Analysts expect a large number of mergers and acquisitions (M&A) to take place among companies, and restructuring seems inevitable to offset worsening profitability.

They say the problem is that there are too many players, and ...